Cargando…

Applications of Neuroimaging to Disease-Modification Trials in Alzheimer’s Disease

Critical to development of new therapies for Alzheimer’s disease (AD) is the ability to detect clinical or pathological change over time. Clinical outcome measures typically used in therapeutic trials have unfortunately proven to be relatively variable and somewhat insensitive to change in this slow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fleisher, Adam S., Donohue, Michael, Chen, Kewei, Brewer, James B., Aisen, Paul S., the Alzheimer’s Disease Neuroimaging Initiative
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444278/ https://www.ncbi.nlm.nih.gov/pubmed/19847051 http://dx.doi.org/10.3233/BEN-2009-0241

Ejemplares similares

Standardized quality metric system for structural brain magnetic resonance images in multi-center neuroimaging study
por: Osadebey, Michael E., et al.
Publicado: (2018)

Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
por: De Velasco Oriol, Javier, et al.
Publicado: (2019)

Structural Neuroimaging in the Detection and Prognosis of Pre-Clinical and Early AD
por: Fennema-Notestine, Christine, et al.
Publicado: (2009)

The Combination of Functional and Structural MRI Is a Potential Screening Tool in Alzheimer’s Disease
por: Huang, Chun-Chao, et al.
Publicado: (2018)

Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer’s disease
por: Upadhyaya, Yurika, et al.
Publicado: (2020)

Topological Measurements of DWI Tractography for Alzheimer's Disease Detection
por: Amoroso, Nicola, et al.
Publicado: (2017)

Structural Brain Imaging Phenotypes of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) Found by Hierarchical Clustering
por: Kärkkäinen, Mikko, et al.
Publicado: (2020)

Protective Factors Modulate the Risk of Beta Amyloid in Alzheimer's Disease
por: Zhou, Bin, et al.
Publicado: (2020)

Classification of Alzheimer's and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET
por: Nozadi, Seyed Hossein, et al.
Publicado: (2018)

Comparison of nine tractography algorithms for detecting abnormal structural brain networks in Alzheimer’s disease
por: Zhan, Liang, et al.
Publicado: (2015)

Late-life obesity is a protective factor for prodromal Alzheimer’s disease: a longitudinal study
por: Sun, Zhen, et al.
Publicado: (2020)

Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer's Disease or Mild Cognitive Impairment
por: Li, Lanlan, et al.
Publicado: (2021)

Plasma sex hormone-binding globulin predicts neurodegeneration and clinical progression in prodromal Alzheimer's disease
por: Xu, Wei, et al.
Publicado: (2020)

Metabolically healthy obesity reduces the risk of Alzheimer’s disease in elders: a longitudinal study
por: Ma, Ling-Zhi, et al.
Publicado: (2019)

Functional Evolving Patterns of Cortical Networks in Progression of Alzheimer's Disease: A Graph-Based Resting-State fMRI Study
por: Li, Wei, et al.
Publicado: (2020)

Tissue-Based MRI Intensity Standardization: Application to Multicentric Datasets
por: Robitaille, Nicolas, et al.
Publicado: (2012)

Identifying the Alteration Patterns of Brain Functional Connectivity in Progressive Mild Cognitive Impairment Patients: A Longitudinal Whole-Brain Voxel-Wise Degree Analysis
por: Deng, Yanjia, et al.
Publicado: (2016)

Multimodal MRI-based imputation of the Aβ+ in early mild cognitive impairment
por: Tosun, Duygu, et al.
Publicado: (2014)

Study of the Influence of Age in (18)F-FDG PET Images Using a Data-Driven Approach and Its Evaluation in Alzheimer's Disease
por: Jiang, Jiehui, et al.
Publicado: (2018)

A Comprehensive Investigation of the Potential Role of Lipoproteins and Metabolite Profile as Biomarkers of Alzheimer's Disease Compared to the Known CSF Biomarkers
por: Nasab, Azam Sajjadi, et al.
Publicado: (2023)

Frequency Specific Effects of ApoE ε4 Allele on Resting-State Networks in Nondemented Elders
por: Liang, Ying, et al.
Publicado: (2017)

CSF-Targeted Proteomics Indicate Amyloid-Beta Ratios in Patients with Alzheimer's Dementia Spectrum
por: Behzad, Maryam, et al.
Publicado: (2023)

Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study
por: Swaminathan, Shanker, et al.
Publicado: (2011)

Q & A: The Alzheimer's disease neuroimaging initiative
por: Aisen, Paul S
Publicado: (2011)

Bayesian latent time joint mixed-effects model of progression in the Alzheimer's Disease Neuroimaging Initiative
por: Li, Dan, et al.
Publicado: (2018)

Cloud-Based Brain Magnetic Resonance Image Segmentation and Parcellation System for Individualized Prediction of Cognitive Worsening
por: Sakamoto, Ryo, et al.
Publicado: (2019)

A Real-Time Clinical Decision Support System, for Mild Cognitive Impairment Detection, Based on a Hybrid Neural Architecture
por: Suárez-Araujo, Carmen Paz, et al.
Publicado: (2021)

Journey to the other side of the brain: asymmetry in patients with chronic mild or moderate traumatic brain injury
por: Ross, David E, et al.
Publicado: (2023)

A simulation study comparing slope model with mixed-model repeated measure to assess cognitive data in clinical trials of Alzheimer's disease
por: Chen, Yun-Fei, et al.
Publicado: (2018)

Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease
por: Zimmer, Jennifer A., et al.
Publicado: (2021)

Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease
por: Insel, Philip S, et al.
Publicado: (2015)

The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer’s disease biomarkers in down syndrome
por: Rafii, Michael S., et al.
Publicado: (2015)

Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial
por: van Dyck, Christopher H., et al.
Publicado: (2019)

Cross-validation of optimized composites for preclinical Alzheimer's disease
por: Donohue, Michael C., et al.
Publicado: (2016)

Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease
por: Veitch, Dallas P., et al.
Publicado: (2021)

Neuroimaging Biomarkers for Alzheimer’s Disease
por: Márquez, Freddie, et al.
Publicado: (2019)

Application of modern neuroimaging technology in the diagnosis and study of Alzheimer's disease
por: Zeng, Hong-Mei, et al.
Publicado: (2020)

The relative efficiency of time-to-progression and continuous measures of cognition in presymptomatic Alzheimer's disease
por: Li, Dan, et al.
Publicado: (2019)

Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease
por: Brickman, Adam M., et al.
Publicado: (2022)

Neuroanatomical spread of amyloid β and tau in Alzheimer’s disease: implications for primary prevention
por: Insel, Philip S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iu3lofiqnfhu19ttuhjkcpjrb3